openPR Logo
Press release

Renal Denervation Market With Analysis of New Business Opportunities After Covid-19 Impact (2022 - 2030)

11-16-2022 11:11 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Renal Denervation Market With Analysis of New Business

The renal denervation market has witnessed significant growth in the past decade, owing to surge in incidence of hypertension and change in blood pressure. Furthermore, upsurge in consumption of alcohol and fast-foods have caused hypertension, which fuel the renal denervation market. Moreover, improvement in infrastructure and rise in technological advancements in medical devices propel the renal denervation market growth.

As per research conducted by Allied Market Research, the Renal Denervation Market size was valued at $156,327.4 thousand in 2020, and is estimated to reach $4,555,983.0 thousand by 2030, growing at a CAGR of 40.7% from 2021 to 2030. The report offers an extensive analysis of changing market trends, top segments, major investment pockets, regional scenarios, value chain, and competitive landscape.

๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐…๐ซ๐ž๐ž ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐Ž๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

https://www.alliedmarketresearch.com/request-sample/522

Increasing prevalence and incidence of hypertension and blood pressure, changing people's lifestyle, improving health infrastructure in developing countries, and the cost-effectiveness of renal denervation procedure compared to other multidrug therapies are driving growth of the market. However, the rigid approval process for renal denervation devices and the patient discomfort and pain that occur during the procedure hinder market growth.

(๐ˆ๐ง ๐ญ๐จ๐๐š๐ฒ'๐ฌ ๐œ๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ, ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐ข๐ฌ ๐š ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ฌ๐ญ๐ž๐ฉ ๐ข๐ง ๐ข๐๐ž๐ง๐ญ๐ข๐Ÿ๐ฒ๐ข๐ง๐  ๐ญ๐ก๐ž ๐œ๐จ๐ซ๐ซ๐ž๐œ๐ญ ๐ญ๐š๐ซ๐ ๐ž๐ญ ๐œ๐จ๐ง๐ฌ๐ฎ๐ฆ๐ž๐ซ๐ฌ ๐š๐ง๐ ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ข๐ง๐  ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ฌ๐ž๐ ๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ ๐Ÿ๐จ๐ซ ๐ญ๐ก๐ž๐ข๐ซ ๐›๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐ง๐ž๐ž๐๐ฌ. ๐–๐ก๐ข๐ฅ๐ž ๐Ÿ๐จ๐ซ๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐ง๐  ๐ญ๐ก๐ž๐ฌ๐ž ๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง๐ฌ, ๐ž๐ฏ๐ž๐ซ๐ฒ ๐Ÿ๐š๐œ๐ž๐ญ ๐š๐ง๐ ๐ฌ๐ฉ๐ž๐œ๐ข๐Ÿ๐ข๐œ ๐ฉ๐ซ๐จ๐›๐ฅ๐ž๐ฆ ๐ฉ๐ซ๐ž๐ฌ๐ž๐ง๐ญ๐ž๐ ๐›๐ฒ ๐ญ๐ก๐ž ๐ฉ๐š๐ซ๐ญ๐ข๐œ๐ฎ๐ฅ๐š๐ซ ๐ฌ๐ž๐œ๐ญ๐จ๐ซ ๐ข๐ฌ ๐ญ๐ก๐จ๐ซ๐จ๐ฎ๐ ๐ก๐ฅ๐ฒ ๐œ๐จ๐ง๐ฌ๐ข๐๐ž๐ซ๐ž๐. ๐ˆ๐ญ ๐š๐ฅ๐ฌ๐จ ๐œ๐จ๐ง๐ฌ๐ข๐๐ž๐ซ๐ฌ ๐ง๐ฎ๐ฆ๐ž๐ซ๐จ๐ฎ๐ฌ ๐ ๐จ๐ฏ๐ž๐ซ๐ง๐ฆ๐ž๐ง๐ญ ๐ซ๐ž๐Ÿ๐จ๐ซ๐ฆ๐ฌ, ๐ญ๐ก๐ž ๐œ๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐ข๐ฏ๐ž ๐ž๐ง๐ฏ๐ข๐ซ๐จ๐ง๐ฆ๐ž๐ง๐ญ, ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ž๐ซ ๐›๐ž๐ก๐š๐ฏ๐ข๐จ๐ฎ๐ซ, ๐œ๐ฎ๐ซ๐ซ๐ž๐ง๐ญ ๐š๐ง๐ ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐›๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐ฌ๐ญ๐ซ๐š๐ญ๐ž๐ ๐ข๐ž๐ฌ, ๐š๐ง๐ ๐ซ๐š๐ฉ๐ข๐๐ฅ๐ฒ ๐œ๐ก๐š๐ง๐ ๐ข๐ง๐  ๐ญ๐ž๐œ๐ก๐ง๐ข๐œ๐š๐ฅ ๐›๐ซ๐ž๐š๐ค๐ญ๐ก๐ซ๐จ๐ฎ๐ ๐ก๐ฌ. ๐ˆ๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐š๐ข๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐Ÿ๐จ๐ซ๐ฆ๐ฎ๐ฅ๐š๐ญ๐ข๐จ๐ง ๐จ๐Ÿ ๐›๐ฎ๐ฌ๐ข๐ง๐ž๐ฌ๐ฌ ๐ฉ๐ฅ๐š๐ง๐ฌ ๐š๐ง๐ ๐ฉ๐จ๐ฅ๐ข๐œ๐ข๐ž๐ฌ.)

Increasing prevalence and incidence of hypertension and blood pressure, changing lifestyle of the people, improvement of healthcare infrastructure in developing countries, and cost effectiveness of the renal denervation procedure as compared to other multidrug treatment therapies propel the market growth. However, stringent approval process for renal denervation devices, and patient discomfort and pain that arises during the procedure hamper the market growth.

However, during the pandemic, various manufacturers in the renal denervation market had to stop their business in countries such as China, the U.S., and India. Thisbreak directly impacted sales of renal denervation companies. In addition, lack of manpower and raw materials also constricted supply of equipment of renal denervation that has negatively influenced the growth of the market. However, reopening of production facilities and introduction of vaccines for coronavirus disease are anticipated to lead to re-opening of renal denervation companies.

๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐…๐จ๐ซ ๐‚๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง:

https://www.alliedmarketresearch.com/request-for-customization/522

The renal denervation market is expected to witness significant growth in the near future. The renal denervation market has attracted interest from the medical and healthcare sector due to the increase in high blood pressure worldwide. In addition, the acquisition of alternative and better technologies for equipment-saving systems, such as micro-perfusion, and the expansion of medical equipment in emerging countries are expected to drive market growth. For example, Mercator MedSystem's denervation technology is based on low infusion. It delivers chemicals to one area to damage the renal arteries, which helps lower the patient's blood pressure.

๐ˆ๐ง๐ญ๐ž๐ซ๐ž๐ฌ๐ญ๐ž๐ ๐ˆ๐ง ๐๐ซ๐จ๐œ๐ฎ๐ซ๐ข๐ง๐  ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ? ๐•๐ข๐ฌ๐ข๐ญ ๐‡๐ž๐ซ๐ž:

https://www.alliedmarketresearch.com/purchase-enquiry/522

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Renal Denervation Market With Analysis of New Business Opportunities After Covid-19 Impact (2022 - 2030) here

News-ID: 2809269 • Views: โ€ฆ

More Releases from Allied Market Research

Robo Advisory Market Expected to Surge from $7.9 Billion (2022) to $129.5 Billio โ€ฆ
Allied Market Research published a report, titled, "Robo Advisory Market by Business Model (Pure Robo Advisors and Hybrid Robo Advisors), Provider (Fin-Tech Robo-Advisors, Banks, Traditional Wealth Managers, and Others), Service Type (Direct Plan-based/Goal-based and Comprehensive Wealth Advisory), and End User (Retail Investor and High Net Worth Individuals (HNIs)): Global Opportunity Analysis and Industry Forecast, 2023-2032". According to the report, the global robo advisory industry generated $7.94 billion in 2022, andโ€ฆ
AI in Banking Market Set to Reach $64.03 Billion by 2030, Growing at a Strong 32 โ€ฆ
Allied Market Research published a report, titled, "AI in Banking Market by Component (Solution and Service), Enterprise Size (Large Enterprise and SMEs), Applications (Risk Management Compliance & Security, Customer Service, Back Office/Operations, Financial Advisory and Others) and Technology (Machine Learning & Deep Learning, Natural Language Processing (NLP), Computer Vision and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030."According to the report published by Allied Market Research, the global AI inโ€ฆ
U.S. Insurance Third-party Administrator Market Expected to Reach $243.26 Billio โ€ฆ
According to a recent report published by Allied Market Research, titled, "U.S. Insurance Third-party Administrator Market by Service Type, End User, and Enterprise Size: Opportunity Analysis and Industry Forecast, 2021-2030," the U.S. insurance third-party administrator market was valued at $156.08 billion in 2020, and is projected to reach $243.26 billion by 2030, growing at a CAGR of 4.6% from 2021 to 2030. Get a Sample Copy of this Report : https://www.alliedmarketresearch.com/request-sample/A14535 Third-partyโ€ฆ
Open Banking Market : Opportunity Analysis and Industry Forecast, 2020-2031
The global open banking market was valued at $13.9 billion in 2020, and is projected to reach $123.7 billion by 2031, growing at a CAGR of 22.3% from 2022 to 2031. โžก๏ธRequest Research Report Sample & TOC : https://www.alliedmarketresearch.com/request-sample/3840 Drivers, Restraints, and Opportunities Supportive government regulations, enhanced overall customer engagement with the help of open banking APIs, and rise in adoption of new applications and services drive the growth of the global openโ€ฆ

All 5 Releases


More Releases for Renal

Advancements in Renal Dialysis Equipment Trend: A Crucial Influence on the Renal โ€ฆ
What market dynamics are playing a key role in accelerating the growth of the renal dialysis equipment market? The escalating incidence of chronic kidney disease is projected to boost the expansion of the renal dialysis equipment market. Chronic kidney disease, a term that describes the slow and progressive decline of kidney function, can ultimately result in kidney failure and other severe health conditions. This disease is linked with several risk factorsโ€ฆ
Renal Osteodystrophy Market: An In-Depth Analysis
The Renal Osteodystrophy Market was valued at approximately USD 2.4 billion in 2023 and is projected to reach around USD 7.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 12.5% from 2024 to 2032. Renal Osteodystrophy Market Overview The Renal Osteodystrophy Market is experiencing significant growth, driven by the increasing prevalence of chronic kidney disease (CKD) and the associated bone disorders. Advancements in diagnostic techniques have enhanced earlyโ€ฆ
Shaping the Renal Dialysis Equipment Market in 2025: Advancements in Renal Dialy โ€ฆ
How Big Is the Renal Dialysis Equipment Market Expected to Be, and What Will Its Growth Rate Be? In recent years, the renal dialysis equipment market has seen robust growth. It's projected to increase from $19.52 billion in 2024 to $20.92 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 7.2%. Factors contributing to growth in the historic period include comprehensive training and support programs, substantial research and developmentโ€ฆ
Transforming the Veterinary Renal Disease Market in 2025: Increasing Pet Ownersh โ€ฆ
"What Is the Expected Size and Growth Rate of the Veterinary Renal Disease Market? The market size for veterinary kidney diseases has seen profound growth recently. It is set to expand from $15.5 billion in 2024 to $16.63 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. Several factors contributed to this growth during the historical period, including heightened initiatives to increase disease awareness, a shift inโ€ฆ
Renal Cancer Pipeline Outlook Report 2024
DelveInsight's, "Renal Cancer Pipeline Insight 2024" report provides comprehensive insights about 75+ Renal Cancer companies and 80+ pipeline drugs in the Renal Cancer pipeline landscape. It covers the Renal Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Renal Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeawaysโ€ฆ
Renal Biomarker Market to register a CAGR of 7.0% by 2026: Rising Prevalence of โ€ฆ
Future Market Insights delivers key insights on the global renal biomarker market in a new report titled โ€œRenal Biomarker Market: Global Industry Analysis and Opportunity Assessment, 2016โ€“2026.โ€ In terms of revenue, the global renal biomarker market is projected to register a healthy CAGR of 7.0% over the forecast period. In this report, Future Market Insights throws light on the various factors and trends impacting market growth over the forecast periodโ€ฆ